Harsha Nagarajarao is a Cardiology physician. OpenAlex indexes 31 publications with 395 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
611 E Douglas Rd Ste 208
Mishawaka, IN 465451465
Telephone
574-335-6700Provider last certified this registry record 27 Mar 2024.
Industry payments
25 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20257 payments
- Shockwave Medical, IncProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.4%Beta blocker21.1%Metoprolol Succinate50%Carvedilol29%Metoprolol Tartrate11%Atenolol4%Sotalol3%Propranolol Hcl3%Part D<11 patientsStatin14.2%Rosuvastatin Calcium55%Atorvastatin Calcium40%Simvastatin5%Part D<11 patients+ 17 more classes in this area
Blood & clotting
15.4%Factor Xa inhibitor9%Eliquis93%Xarelto7%Part D<11 patientsP2Y12 inhibitor5.8%Clopidogrel100%Part D≥76 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.4%Potassium supplement2.2%Potassium Chloride74%Klor-Con M2027%Part D<11 patientsSGLT2 inhibitor0.9%Jardiance100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- TCT-355 PrevaLence of CoronAry ArTery Anomalies Among HispaNics in the US-Mexico Border Region: pLATINum Study
Journal of the American College of Cardiology
2024 - CONSTRICTIVE PERICARDITIS WITH CONCOMITANT SEVERE MITRAL REGURGITATION: A DIAGNOSTIC DILEMMA
Journal of the American College of Cardiology
2021 - A RARE ENTITY THAT SHOULD NOT BE FORGOTTEN! NONBACTERIAL THROMBOTIC ENDOCARDITIS (NBTE)
Journal of the American College of Cardiology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”